Verity Asset Management Inc. Has $639,000 Stock Holdings in Worthington Enterprises, Inc. (NYSE:WOR)

Verity Asset Management Inc. lowered its position in shares of Worthington Enterprises, Inc. (NYSE:WOR) by 1.5% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm owned 15,929 shares of the industrial products company’s stock after selling 249 shares during the quarter. Verity Asset Management Inc.’s holdings in Worthington Enterprises were worth $639,000 as of its most recent SEC filing.

Several other large investors have also recently bought and sold shares of the company. KBC Group NV increased its position in shares of Worthington Enterprises by 45.1% in the 3rd quarter. KBC Group NV now owns 1,136 shares of the industrial products company’s stock valued at $47,000 after buying an additional 353 shares in the last quarter. nVerses Capital LLC acquired a new position in Worthington Enterprises in the third quarter valued at about $83,000. Point72 Asia Singapore Pte. Ltd. bought a new stake in shares of Worthington Enterprises in the third quarter worth about $85,000. Point72 DIFC Ltd acquired a new stake in shares of Worthington Enterprises during the third quarter worth about $110,000. Finally, Eastern Bank bought a new position in shares of Worthington Enterprises during the 3rd quarter valued at about $121,000. Institutional investors own 51.59% of the company’s stock.

Worthington Enterprises Stock Down 1.4 %

WOR stock opened at $41.32 on Tuesday. The company has a debt-to-equity ratio of 0.32, a current ratio of 3.56 and a quick ratio of 2.50. The stock has a market capitalization of $2.07 billion, a P/E ratio of 49.78 and a beta of 1.24. Worthington Enterprises, Inc. has a fifty-two week low of $37.88 and a fifty-two week high of $69.96. The business has a 50-day moving average of $40.86 and a 200-day moving average of $42.43.

Worthington Enterprises (NYSE:WOR) last released its quarterly earnings results on Tuesday, December 17th. The industrial products company reported $0.60 earnings per share for the quarter, topping analysts’ consensus estimates of $0.52 by $0.08. The firm had revenue of $274.05 million during the quarter, compared to the consensus estimate of $273.77 million. Worthington Enterprises had a return on equity of 14.70% and a net margin of 3.66%. The business’s revenue was down 8.1% on a year-over-year basis. During the same quarter in the prior year, the firm posted $0.78 EPS. On average, sell-side analysts anticipate that Worthington Enterprises, Inc. will post 2.67 earnings per share for the current fiscal year.

Worthington Enterprises Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, March 28th. Investors of record on Friday, March 14th will be given a $0.17 dividend. This represents a $0.68 dividend on an annualized basis and a yield of 1.65%. Worthington Enterprises’s dividend payout ratio (DPR) is currently 81.93%.

Analysts Set New Price Targets

Several analysts have commented on the stock. Canaccord Genuity Group raised their target price on shares of Worthington Enterprises from $46.00 to $49.00 and gave the stock a “hold” rating in a report on Thursday, December 19th. Seaport Res Ptn raised shares of Worthington Enterprises to a “strong-buy” rating in a research report on Wednesday, January 29th. One research analyst has rated the stock with a sell rating, three have assigned a hold rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Hold” and an average target price of $46.00.

About Worthington Enterprises

Worthington Enterprises, Inc operates as an industrial manufacturing company. It operates through three segments: Building Products, Consumer Products, and Sustainable Energy Solutions. The Building Products segment sells refrigerant and LPG cylinders, well water and expansion tanks, fire suppression tanks, chemical tanks, and foam and adhesive tanks for gas producers, and distributors.